TimothyJWilkinMD

Infectious Disease • San Diego, CA

Associate Professor, Medicine, Weill Cornell Medical College

Join to view full profile

Dr. Wilkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wilkin's full profile

Already have an account?

Office
4168 Front St
San Diego, CA 92103
Phone+1 800-926-8273

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 1999 - 2002
University of ChicagoResidency, Internal Medicine, 1996 - 1999
Ohio State University College of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 2024 - 2026
NY State Medical License 1999 - 2026
IL State Medical License 1996 - 1999
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015

Clinical Trials

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection Start of enrollment: 2007 Nov 01
Completed
Phase 2
Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression Start of enrollment: 2009 Jan 01
Completed
Not Applicable
HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women Start of enrollment: 2012 Apr 04
Completed
Not Applicable
Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions Start of enrollment: 2015 Dec 28
Active, not recruiting
Phase 3
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection Start of enrollment: 2014 May 30
Completed
Phase 1
Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions Start of enrollment: 2015 Apr 01
Completed
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) Start of enrollment: 2015 Dec 21
Completed
Phase 1, Phase 2
PREPARE (A5361s) Substudy of REPRIEVE (A5332) Start of enrollment: 2017 Feb 28
Completed
Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption Start of enrollment: 2021 May 21
Recruiting
Phase 1
3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803) Start of enrollment: 2022 Dec 07
Recruiting
Phase 1
Roles: Contact
Study of Tecovirimat for Human Monkeypox Virus Start of enrollment: 2022 Sep 12
Recruiting
Phase 3
Roles: Study Chair
Join now to see all

Publications & Presentations

PubMed

Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection.
Rosie Mngqibisa, Huichao Chen, Catherine Godfrey, Motshedisi Sebitloane, Unoda Chakalisa
AIDS Research and Therapy. 2024-12-30
CROI 2024: The Challenges of Sustained Viral Suppression, Advanced HIV Disease, and Ending the HIV Epidemic Targets.
Shauna H Gunaratne, Barbara S Taylor, Jason Zucker, Timothy J Wilkin, Hong-Van Tieu
Topics in Antiviral Medicine. 2024-08-12
Expectations of preventative benefits and risk behaviors in a randomized trial evaluating oral HIV preexposure prophylaxis candidates.
Jeremy Sugarman, Brian W Weir, Chen Dun, Roy M Gulick, Timothy J Wilkin
AIDS Care. 2024-08-01

Journal Articles

Initial Development and Content Validation of a Health-Related Symptom Index for Persons Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions
Timothy J Wilkin, Joel M Palefsky, Value in Health
A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-Anal High-Grade Dysplasia in HIV-Infected Adults: An AIDS Malignancy Con...
Timothy Wilkin, Jeannette Y Lee, Stephen E Goldstone, Clinical Infectious Diseases

Authored Content

Initial Development and Content Validation of a Health-Related Symptom Index for Persons Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial LesionsAugust 2018

Press Mentions

HIV Patients Fare Well with Mpox TreatmentMay 5th, 2023
NIH Grant to Improve HIV-Related Cancer Care AbroadFebruary 3rd, 2023
UNC Receives NIH Grant to Improve HIV-Related Cancer Care AbroadJanuary 30th, 2023
Join now to see all